|
PRKAG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.43939998703746E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.59240004200024E-09 |
| Normal-vs-Stage2 |
7.59189999977039E-07 |
| Normal-vs-Stage3 |
3.532600E-01 |
| Normal-vs-Stage4 |
1.187940E-02 |
| Stage1-vs-Stage2 |
9.448000E-01 |
| Stage1-vs-Stage3 |
3.836600E-01 |
| Stage1-vs-Stage4 |
4.385800E-01 |
| Stage2-vs-Stage3 |
3.778200E-01 |
| Stage2-vs-Stage4 |
2.630000E-01 |
| Stage3-vs-Stage4 |
7.885600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.47159992261948E-10 |
| Normal-vs-AfricanAmerican |
7.341100E-03 |
| Normal-vs-Asian |
3.600600E-01 |
| Caucasian-vs-AfricanAmerican |
4.007800E-01 |
| Caucasian-vs-Asian |
3.713800E-01 |
| AfricanAmerican-vs-Asian |
7.860200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.38600045171711E-10 |
| Normal-vs-Female |
2.935600E-03 |
| Male-vs-Female |
2.141000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.309500E-02 |
| Normal-vs-Extreme_Weight |
4.00109945175586E-10 |
| Normal-vs-Obese |
2.457600E-03 |
| Normal-vs-Extreme_Obese |
2.20060000000188E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.874600E-01 |
| Normal_Weight-vs-Obese |
7.827000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.105200E-01 |
| Extreme_Weight-vs-Obese |
2.734600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.040600E-01 |
| Obese-vs-Extreme_Obese |
1.977970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.243900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.69989999976706E-07 |
| Normal-vs-Age(61-80Yrs) |
3.55329999868204E-08 |
| Normal-vs-Age(81-100Yrs) |
7.48150430496253E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.882020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.077750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.191700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.662000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.324400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.100030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.86529680590297E-11 |
| Normal-VS-Type2 PRCC |
2.178000E-03 |
| Normal-VS-KIRP CIMP |
7.772000E-01 |
| Normal-VS-Unclassified PRCC |
9.527700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.741170E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.882600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.565400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.102100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.714600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.084800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.0370038988915E-11 |
| Normal-vs-N1 |
7.468400E-01 |
| Normal-vs-N2 |
1.975680E-03 |
| N0-vs-N1 |
1.607380E-01 |
| N0-vs-N2 |
9.202600E-01 |
| N1-vs-N2 |
1.528040E-01 |
|
|
